>>> US GApping Up

In reaction to strong earnings/guidance: JMEI +3.1%.

Select metals/mining stocks trading higher: AUY +3.1%, HL +2.5%, ABX +2.2%, GDX +1.9%, SLV +1.5%, GLD +0.8%, PVG +1.5%, PAAS +1.1% (acquires an additional 10 mln common shares of Maverix Metals through the exercise of 10 mln previously acquired common share purchase warrants).
A few Brazil ADRs/related names are trading higher: VALE +3.9%, GGB +3.8%, SID +2.3%, PBR +1.7%, ITUB +1.3%, BUD +1.2%

Other news:
  • IONS +6.5% and BIIB +2.3% (FDA approves Spinraza/nusinersen, the first drug approved to treat children and adults with spinal muscular atrophy -- marketed by Biogen)
  • REFR +6.1% (light volume - still checking)
  • NVCN +5.2% (continued strength after Friday's 17% move higher)
  • PLX +4.8% (receives confirmation of order for over $24 million of alfataliglicerase to treat Gaucher patients in Brazil)
  • CEMP +4% and TXMD +3.7% (still checking, CEMP closed 14% lower last week)
  • NKTR +2.9% (light volume - being attributed to Shire news),
  • MTL +2% (ticking higher - extended the maturity of the debt on its credit lines until 2022)
  • NVDA +1.6% (continued strength)
  • LMT +0.5% (Lockheed Martin tweeted Friday 'LM CEO just had a good conversation with President Elect Trump; she personally committed to drive down the cost of the F-35')
  • MU +1.2% following last week's 15% move higher; also Barron's profiles long term positive view on Micron)
  • AGN +0.5% (still checking for anything specific)
  • TSLA +0.3% (Tesla Motors and Panasonic will begin manufacturing solar cells and modules in Buffalo, NY)
  • HOLX +0.2% (receives FDA PMA approval for HIV-1 Quant Assay)
  • SRG +0.2% (modestly rebounding on light volume - announces proposed new unsecured credit facility)
Analyst comments: CY +0.3% (ticking higher; Improving U.S autos primed for a better 2017 - Mizuho)